ProfileGDS4718 / 228161_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 28% 32% 19% 26% 24% 24% 29% 26% 31% 23% 39% 24% 29% 29% 28% 34% 25% 21% 29% 20% 27% 24% 35% 25% 24% 28% 34% 22% 28% 21% 20% 26% 23% 36% 28% 26% 32% 25% 26% 22% 28% 26% 21% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4696928
GSM549102patient 115, normal, homogenized [OPG study]4.6201732
GSM549104patient 119, normal, homogenized [OPG study]4.0695819
GSM549108patient 138, normal, homogenized [OPG study]4.4144426
GSM549119patient 077, normal, homogenized [OPG study]4.3114124
GSM549133patient 032, cancer, homogenized [OPG study]4.2614324
GSM549139patient 042, cancer, homogenized [OPG study]4.4698429
GSM549099patient 107, normal, homogenized [OPG study]4.3896126
GSM549109patient 139, normal, homogenized [OPG study]4.608931
GSM549110patient 046, normal, homogenized [OPG study]4.2681623
GSM549114patient 063, normal, homogenized [OPG study]4.8785439
GSM549122patient 082, normal, homogenized [OPG study]4.3086424
GSM549134patient 033, cancer, homogenized [OPG study]4.4800429
GSM549136patient 036, cancer, homogenized [OPG study]4.4502329
GSM549140patient 044, cancer, homogenized [OPG study]4.4156128
GSM549111patient 047, normal, homogenized [OPG study]4.6947834
GSM549113patient 057, normal, homogenized [OPG study]4.2657925
GSM549132patient 031, cancer, homogenized [OPG study]4.1786621
GSM549137patient 038, cancer, homogenized [OPG study]4.4680229
GSM549142patient 047, cancer, homogenized [OPG study]4.2435420
GSM549100patient 110, normal, homogenized [OPG study]4.4353627
GSM549107patient 135, normal, homogenized [OPG study]4.2798924
GSM549115patient 068, normal, homogenized [OPG study]4.7043135
GSM549116patient 072, normal, homogenized [OPG study]4.3041925
GSM549120patient 078, normal, homogenized [OPG study]4.3125724
GSM549131patient 030, cancer, homogenized [OPG study]4.4194828
GSM549118patient 074, normal, homogenized [OPG study]4.698134
GSM549129patient 027, cancer, homogenized [OPG study]4.2441222
GSM549123patient 088, normal, homogenized [OPG study]4.4445228
GSM549124patient 006, cancer, homogenized [OPG study]4.2081821
GSM549126patient 015, cancer, homogenized [OPG study]4.1246920
GSM549128patient 025, cancer, homogenized [OPG study]4.3360426
GSM549103patient 117, normal, homogenized [OPG study]4.2952623
GSM549117patient 073, normal, homogenized [OPG study]4.7678536
GSM549138patient 041, cancer, homogenized [OPG study]4.4207828
GSM549141patient 045, cancer, homogenized [OPG study]4.3132326
GSM549130patient 028, cancer, homogenized [OPG study]4.6640832
GSM549101patient 111, normal, homogenized [OPG study]4.371125
GSM549105patient 128, normal, homogenized [OPG study]4.378626
GSM549106patient 134, normal, homogenized [OPG study]4.1863522
GSM549112patient 048, normal, homogenized [OPG study]4.4529328
GSM549125patient 011, cancer, homogenized [OPG study]4.3931526
GSM549127patient 024, cancer, homogenized [OPG study]4.1511321
GSM549135patient 035, cancer, homogenized [OPG study]4.4069428